Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
4DMedical Ltd ( (AU:4DX) ) has provided an announcement.
4DMedical Ltd has announced the quotation of 480,450 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective December 9, 2025. This move is part of the company’s strategy to enhance its market presence and liquidity, potentially benefiting stakeholders by increasing the accessibility and attractiveness of its shares.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, specializing in advanced imaging solutions. The company focuses on developing innovative diagnostic tools, primarily for respiratory health, to improve patient outcomes and healthcare efficiency.
Average Trading Volume: 5,044,779
Technical Sentiment Signal: Buy
Current Market Cap: A$1.15B
For an in-depth examination of 4DX stock, go to TipRanks’ Overview page.